###begin article-title 0
###xml 57 58 50 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Signal Regulatory Protein alpha Negatively Regulates beta2 Integrin-Mediated Monocyte Adhesion, Transendothelial Migration and Phagocytosis
###end article-title 0
###begin p 1
Conceived and designed the experiments: CYZ KZ. Performed the experiments: DQL LML YLG RB CW ZB KZ. Analyzed the data: DQL LML YLG RB KZ. Contributed reagents/materials/analysis tools: CYZ. Wrote the paper: KZ.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 155 156 140 141 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Signal regulate protein alpha (SIRPalpha) is involved in many functional aspects of monocytes. Here we investigate the role of SIRPalpha in regulating beta2 integrin-mediated monocyte adhesion, transendothelial migration (TEM) and phagocytosis.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 150 151 143 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 193 194 183 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 492 493 467 468 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 568 569 536 537 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 869 870 822 823 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 275 280 <span type="species:ncbi:9606">human</span>
THP-1 monocytes/macropahges treated with advanced glycation end products (AGEs) resulted in a decrease of SIRPalpha expression but an increase of beta2 integrin cell surface expression and beta2 integrin-mediated adhesion to tumor necrosis factor-alpha (TNFalpha)-stimulated human microvascular endothelial cell (HMEC-1) monolayers. In contrast, SIRPalpha overexpression in THP-1 cells showed a significant less monocyte chemotactic protein-1 (MCP-1)-triggered cell surface expression of beta2 integrins, in particular CD11b/CD18. SIRPalpha overexpression reduced beta2 integrin-mediated firm adhesion of THP-1 cells to either TNFalpha-stimulated HMEC-1 monolayers or to immobilized intercellular adhesion molecule-1 (ICAM-1). SIRPalpha overexpression also reduced MCP-1-initiated migration of THP-1 cells across TNFalpha-stimulated HMEC-1 monolayers. Furthermore, beta2 integrin-mediated THP-1 cell spreading and actin polymerization in response to MCP-1, and phagocytosis of bacteria were both inhibited by SIRPalpha overexpression.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 35 36 28 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
SIRPalpha negatively regulates beta2 integrin-mediated monocyte adhesion, transendothelial migration and phagocytosis, thus may serve as a critical molecule in preventing excessive activation and accumulation of monocytes in the arterial wall during early stage of atherosclerosis.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 136 139 136 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Gerrity1">[1]</xref>
###xml 141 144 141 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Ross1">[2]</xref>
###xml 146 149 146 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Rosenfeld1">[3]</xref>
###xml 283 286 283 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Boisvert1">[4]</xref>
###xml 693 696 693 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Dong1">[5]</xref>
###xml 754 755 751 752 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 927 930 924 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Springer1">[6]</xref>
###xml 1087 1090 1084 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Campbell1">[7]</xref>
###xml 1213 1214 1207 1208 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1331 1334 1325 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Han1">[8]</xref>
Recruitment of monocytes from circulation to inflamed tissues plays a pivotal role in the initiation and progression of atherosclerosis [1], [2], [3]. After migrated to lesion region, monocytes are rapidly differentiated into macrophage which engulf lipids and form the fatty streak [4]. Although the mechanisms that govern the delivery of monocytes from circulation to inflammatory site are not fully understood, the process of monocyte diapedesis has been regarded as a multi-step event that is sequentially regulated by a panel of adhesion molecules and signaling pathways. E- and P-selectins are involved in the initial reversible adherence of monocytes to the endothelial cell monolayers [5]. The following firm adhesion is mediated by monocyte beta2 integrins,including CD11a/CD18 and CD11b/CD18,that recognize vascular cell adhesion molecule-1(VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) on endothelial cells [6]. Firm adhesion of monocytes requires activation of integrins, which can be triggered by agonist-induced activation of G protein-coupled chemokine receptors [7]. Monocytes express CC chemokine receptor 2 (CCR2), which binds monocyte chemoattractant protein-1 (MCP-1), leading to beta2 integrin-mediated firm adhesion and subsequent transmigration of adhered monocytes through the vascular endothelium [8].
###end p 9
###begin p 10
###xml 78 81 70 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Oshima1">[9]</xref>
###xml 86 90 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Jiang1">[10]</xref>
###xml 95 99 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Timms1">[11]</xref>
###xml 104 108 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Saginario1">[12]</xref>
###xml 115 119 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Patel1">[13]</xref>
###xml 229 233 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Barclay1">[14]</xref>
###xml 235 239 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Liu1">[15]</xref>
###xml 813 817 789 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Fujioka1">[16]</xref>
###xml 819 823 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Kharitonenkov1">[17]</xref>
###xml 890 894 866 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Barclay1">[14]</xref>
###xml 1007 1011 979 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Yamao1">[18]</xref>
###xml 1013 1017 985 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Okazawa1">[19]</xref>
###xml 1052 1056 1024 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Smith1">[20]</xref>
###xml 1061 1069 1033 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1084 1088 1056 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Liu2">[21]</xref>
###xml 1090 1094 1062 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-deVries1">[22]</xref>
###xml 1179 1183 1147 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Liu3">[23]</xref>
###xml 1484 1488 1444 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Inagaki1">[24]</xref>
###xml 1603 1607 1559 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Wu1">[25]</xref>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 558 564 <span type="species:ncbi:9606">humans</span>
Recently signal regulatory protein alpha (SIRPalpha) (also designate as SHPS-1[9], p84[10], BIT[11], MFR[12], MyD-1[13], etc.) has been reported to serve as an important modulator for controlling leukocyte inflammatory responses [14], [15]. As an immunoglobulin superfamily member (IgSF), SIRPalpha is expressed mainly by myeloid. SIRPalpha has a long intracellular domain that contains four tyrosine residues to form two immunoreceptor tyrosine-based inhibition motifs (ITIMs) and this type of signaling structure is highly conserved between mice, rats and humans. Studies have suggested that binding of SIRPalpha with its extracellular ligand CD47 results in phosphorylations of SIRPalpha ITIMs, which in turn, leads to their association with SH2-domain-containing protein tyrosine phosphotases SHP-1 and SHP-2 [16], [17] to delivers signals that regulate a variety of cellular functions [14]. Ligation of SIRPalpha by antibody or CD47 recombinant inhibits many leukocyte functions, including phagocytosis[18], [19], tumour-necrosis factor production[20] and in vitro transmigration[21], [22]. Activation of SIRPalpha by arterial elastic laminae also inhibits monocyte adhesion[23]. Fibroblasts expressing a SIRPalpha mutant lacking ITIMs-containing cytoplasmic tail showed increased formation of focal adhesions and actin stress fibres in response to interaction with extracellular matrix, suggesting that SIRPalpha also plays a role in integrin-mediated cytoskeletal organization [24]. Negative regulatory role of SIRPalpha has also been found in tumor metastasis, survival, and cell transformation [25].
###end p 10
###begin p 11
###xml 333 334 318 319 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 363 364 345 346 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In the present study, to further explore the negative regulatory role of SIRPalpha in various functional aspects of monocytes, we examined the correlation between expression level of SIRPalpha in THP-1 cells and THP-1 cell transmigratory capacity. By overexpressing SIRPalpha in THP-1 cells, we also determined the alteration of beta2 integrin expression and beta2 integrins-mediated cellular functions of monocytes in response to chemoattractant stimulation.
###end p 11
###begin title 12
Materials and Methods
###end title 12
###begin title 13
Reagents and Antibodies
###end title 13
###begin p 14
###xml 158 162 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Valcourt1">[26]</xref>
###xml 540 544 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Zen1">[27]</xref>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 182 188 <span type="species:ncbi:9913">bovine</span>
###xml 477 482 <span type="species:ncbi:9606">human</span>
Recombinant human MCP-1 and TNFalpha, were purchased from PeproTech (Rocky Hill, NJ). AGEs-BSA (AGEs) was prepared according to a method previously described [26]. Briefly, 50 mg/ml bovine serum albimin (BSA) (Fraction V, sterile filtered, Sigma-Aldrich) was incubated with 0.6 M D-ribose or 0.5 M D-glucose and 0.3 M lysine in PBS containing 100 units/ml penicillin and streptomycin for 4 weeks. The unincorporated sugars were removed by dialysis against PBS. Polyclonal anti-human CD11b were generated against C-terminal peptide of CD11b [27]. Polyclonal anti-SIRPalpha antibody (SIRPalpha-ct) was obtained from Chemicon (Temecula, CA). Monoclonal anti-CD11b (OKM-1), and anti-CD11a (TIB-217), prepared in our laboratory from hybridoma, were obtained from American Type Culture Collection (ATCC) (Manassas, VA). Monoclonal anti-CD11c (S-HCL-3, IgG2b) and anti-CCR2 (clone 48607) were obtained from BD Biosciences (San Diego, CA).
###end p 14
###begin title 15
Cells
###end title 15
###begin p 16
###xml 101 104 101 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Han1">[8]</xref>
###xml 398 402 398 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Ades1">[28]</xref>
###xml 741 742 733 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 574 580 <span type="species:ncbi:9913">bovine</span>
THP-1 cells (Chinese Cell Culture Center, Shanghai, China) were cultured and maintained as described [8]. In separated experiments, THP-1 cells were treated with AGEs-BSA (AGEs) at various concentrations overnight. Cells treated with BSA of the same concentration served as controls. Immortalized HMEC-1 was kindly provided by Dr. E.W. Ades (Centers for Disease Control and Prevention, Atlanta, GA)[28] and were grown in MCDB-131 (Invitrogen) supplemented with 10 ng/ml epidermal growth factor (Becton-Dickinson), 1 microg/ml hydrocortisone (Sigma-Aldrich) and 10-15% fetal bovine serum (Hyclone). HMEC-1 cells were seeded on collagen (Sigma-Aldrich)-coated tissue culture plates or permeable Transwell filters (5.0 microm pore size, 0.33 cm2 surface areas, Costar, NY).
###end p 16
###begin title 17
SIRPalpha Overexpression
###end title 17
###begin p 18
###xml 326 327 314 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 403 409 <span type="species:ncbi:9913">bovine</span>
Complete sequence of human SIRPalpha was amplified, inserted into the expression vector pcDNA3.1 (Invitrogen, Carlsbad, CA), and confirmed by DNA sequencing. The transfection of THP-1 cells was conducted via Lipofectmin 2000 (Invitrogen). Briefly, Lipofectmin-SIRPalpha pcDNA3.1 complex (250 microL) was added dropwise to 5x106 THP-1 cells in 20 mL RPMI medium 1640 containing 2% heat-inactivated fetal bovine serum. After 24 h incubation, THP-1 cells were harvested and used for further analysis.
###end p 18
###begin title 19
Immunofluorescence, Confocal Microscopy and Flow Cytometry
###end title 19
###begin p 20
###xml 27 28 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 87 90 84 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Han1">[8]</xref>
###xml 92 96 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Zen2">[29]</xref>
###xml 305 306 299 300 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1083 1087 1073 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Ryu1">[30]</xref>
Surface expressions of beta2-integrins were detected using flow cytometry as described [8], [29]. The relative surface expression was estimated by subtracting the mean fluorescence intensity (MFI) of cells labeled with the nonspecific antibody from that of cells labeled with the antibodies detecting beta2-integrins. All studies consisted of at least three independent experiments. Flow cytometry was performed and data were analyzed using CELLQUEST software (BD Biosciences). The polymerization of actin filaments in THP-1 cells, induced by pretreatment with 10 nM MCP-1 or 25 ng/mL TNFalpha for 30-60 minutes, was determined using rhodamine-conjugated phalloidin staining (Molecular Probes) according to the manufacturer's protocol. Briefly, cells treated with cytokines were fixed with 3.7% paraformaldehyde in PBS for 5 minutes, gently permeabilized with 0.1% Triton X-100, and blocked with 1% BSA in PBS for 30 min followed by rhodamine-conjugated phalloidin staining. In some experiments, cells were treated with cytochalasin D (Sigma-Aldrich) to inhibit actin polymerization [30]. Coverslips were mounted with antifade mounting medium (Molecular Probes). Images were captured and analyzed by a laser scanning confocal microscope equipped with an image processing system (Olympus Microsystems).
###end p 20
###begin title 21
Cell Adhesion Assays
###end title 21
###begin p 22
###xml 244 248 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Luscinskas1">[31]</xref>
###xml 250 254 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Zhang1">[32]</xref>
###xml 504 508 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Zen1">[27]</xref>
###xml 633 637 625 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Ryu1">[30]</xref>
###xml 846 847 822 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1185 1189 1155 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Zen1">[27]</xref>
###xml 334 339 <span type="species:ncbi:9606">human</span>
Confluent HMEC-1 cell monolayers cultured on gelatin (Difco)-coated tissue culture plates or permeable Transwell filters. Monolayers were treated with 25 ng/mL TNFalpha for 6 h to induce VCAM-1 and ICAM-1 expression prior to the adhesion assay [31], [32]. In separate experiments, 24-well plates were coated for 2 h with 10 microg/mL human recombinant VCAM-1 or ICAM-1. THP-1 cells were briefly labeled with 2',7'-bis-(2-carboxyethyl)-6-carboxyfluorescein acetoxymethyl ester (BCECF-AM, Molecular Probes)[27] and then suspended in RPMI 1640 medium containing 0.1% BSA and stimulated with 10 nM MCP-1 for 30 min to activate integrins [30]. In a subset of experiments, monocytes were pre-incubated with 50 microM dibutyl-cAMP (Bt2cAMP) for 30 min to inhibit chemokine-mediated integrin activation. Fluorescently labeled monocytes (approximately2x105 cells/well) were then added to HMEC-1 monolayers or 24-well plates coated with VCAM-1 or ICAM-1, and incubated for 30 min at 37degreesC. Nonadherent monocytes were removed by gentle washing with PBS and the bound cells were measured by a fluorescence plate reader at excitation/emission wavelengths of 485/535 nm (Millipore, Milford, MA)[27].
###end p 22
###begin title 23
Transendothelial Migration (TEM)
###end title 23
###begin p 24
###xml 111 115 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Ryu1">[30]</xref>
###xml 302 303 294 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 529 530 507 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 704 705 682 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 681 686 <span type="species:ncbi:9606">human</span>
Migration of THP-1 cells across TNFalpha-pre-activated HMEC-1 monolayers was performed as previously described [30] with minor modification. Prior to migration assay, HMEC-1 monolayers cultured on gelatin (Difco)-coated transwell filters were treated with 25 ng/mL TNFalpha for 6 h. THP-1 cells (5.0x105/per well) were added to the upper chamber of Transwell inserts containing 200 microl HBSS. 700 microl HBSS containing 10 nM MCP-1 was placed in the bottom chamber. After 90 min and 180 min incubation at 37degreesC under 5% CO2, cells that had transmigrated to the lower chamber were harvested in 1 ml PBS containing 0.1% BSA and labeled with phycoerythrin (PE)-conjugated anti-human CD14 antibody. 106 FITC-conjugated standard beads (PharMingen, La Jolla, CA) were added to the cell suspension and the number of THP-1 cells was counted until 10,000 beads were counted by flow cytometry. All experiments were repeated as triplicated fashion in at least three independent studies.
###end p 24
###begin title 25
Phagocytosis of Fluorescein Conjugated Bacteria
###end title 25
###begin p 26
###xml 119 126 111 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 164 168 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Sharlow1">[33]</xref>
###xml 174 181 166 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 278 280 270 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 287 289 279 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 295 296 287 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 119 131 <span type="species:ncbi:83333">E. coli K-12</span>
###xml 174 181 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
THP-1 cells transfected with SIRPalpha or Mock vector were incubated for 3 h with 100 microl of fluorescein-conjugated E. coli K-12 bioparticles (Molecular Probes) [33]. The E. coli suspension was aspirated, and after three washes with Hank's balanced salt solution devoid of Ca2+ and Mg2+ (HBSS-), cell associated fluorescence was observed under microscopy or measured using a SpectraMax microtiter plate reader (Molecular Devices).
###end p 26
###begin title 27
Western Blot
###end title 27
###begin p 28
###xml 168 169 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
THP-1 cells were solubilized in lysis buffer containing 1% Triton X-100 and a panel of protease inhibitors at 4degreesC. Pellet was removed after centrifuged at 13,000xg for 5 minutes. Supernatant was normalized for total protein, and loaded on 10% SDS-PAGE. After electrophoresis and transfer onto Hybond membranes, membranes were blocked with 5% non-fat milk. Antigens were detected using suitable primary antibodies followed by incubation with HRP-conjugated antibodies and ECL (Amersham) detection.
###end p 28
###begin title 29
Statistical Analysis
###end title 29
###begin p 30
###xml 34 35 34 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Data were analyzed by the Student t test; P values of <0.05 were regarded as significant differences (*, p<0.05; **, p<0.01).
###end p 30
###begin title 31
Results
###end title 31
###begin title 32
###xml 75 76 68 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Downregulation of SIRPalpha in THP-1 cells is correlated with enhanced beta2 integrin-mediated cell adhesion
###end title 32
###begin p 33
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Miyata1">[34]</xref>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Peppa1">[35]</xref>
###xml 343 352 343 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g001">Figure 1A</xref>
###xml 767 774 756 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g001">Fig. 1B</xref>
###xml 974 975 956 957 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1054 1061 1036 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g001">Fig. 1C</xref>
###xml 1214 1221 1192 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g001">Fig. 1D</xref>
###xml 1397 1404 1371 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g001">Fig. 1E</xref>
It has been reported that advanced glycation end products (AGEs) are involved in tissue damage associated with diabetic complications and aging [34], [35]. Although the mechanism is still not clear, monocytes tend to be activated by AGEs and show an enhanced chemotaxis under such inflammatory conditions. As shown by Western blot analysis in Figure 1A, the expression of SIRPalpha in THP-1 cells was decreased after AGEs treatment. Served as controls, beta-actin level was not altered. The down-regulation of SIRPalpha in AGEs-treated THP-1 cells is contrast to that of receptor for advanced glycation end products (RAGE) and junctional adhesion molecule-like protein (JAML), which expression levels are both increased after AGEs treatment (Zen et al, unpublished). Fig. 1B showed the quantitative analysis of SIRPalpha downregulation by AGEs in a dose-dependent fashion. Interestingly, AGEs-treated THP-1 cells showed a significant enhanced cell surface expression of beta2 integrins, in particular CD11b/CD18, in response to the stimulation of MCP-1 (Fig. 1C). Also, compared to BSA-treated THP-1 cells, AGEs- treated THP-1 cells had a higher percentage of cell adhesion to TNFalpha-activated HMEC-1 monolayer (Fig. 1D). In response to MCP-1, AGEs-treated THP-1 cells also showed an increased transmigration across TNFalpha-activated HMEC-1 monolayers compared to THP-1 cells treated with BSA (Fig. 1E). Together, these results suggest that AGEs treatment can activate THP-1 cells and enhance cell chemotaxis.
###end p 33
###begin title 34
###xml 139 140 132 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 159 160 149 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Down-regulation of SIRPalpha in THP-1 cells treated with BSA-AGEs is correlated to enhanced THP-1 cell surface expression of leukocyte beta2 integrins and beta2 integrins-mediated THP-1 cell inflammatory responses.
###end title 34
###begin p 35
###xml 258 259 241 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 419 420 396 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
In these experiments, THP-1 cells were treated with BSA-AGEs (AGEs) or BSA overnight at 37degreesC. A: SIRPalpha protein level in THP-1 cells; B: reduction of SIRPalpha protein level by AGEs in dose-dependent fashion; C: Cell surface expression level of beta2 integrins in THP-1 cells; D and E: THP-1 cell adhesion to and migration across TNFalpha-pre-activated HMEC-1 monolayers, respectively. All data are mean+/-SD (n = 3) of three independent experiments.
###end p 35
###begin title 36
Overexpression of SIRPalpha in THP-1 cells inhibits MCP-1-induced cell surface expression of beta2 integrins
###end title 36
###begin p 37
###xml 117 118 110 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 147 148 137 138 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 293 302 279 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g002">Figure 2A</xref>
###xml 642 649 612 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g002">Fig. 2B</xref>
###xml 381 386 <span type="species:ncbi:9606">human</span>
To define the role of SIRPalpha in regulating monocyte inflammatory response, we characterized the alteration of beta2 integrin expression and beta2 integrin-mediated cell adhesion, migration and phagocytosis in THP-1 cells after significantly increase SIRPalpha expression level. As shown in Figure 2A, immunoblot analysis showed that the delivery of the pcDNA3.1 vector encoding human SIRPalpha into THP-1 cells profoundly enhanced SIRPalpha expression. Compared to mock-transfected THP-1 cells, SIRPalpha-transfected THP-1 cells also showed a significantly enhanced expression of SIRPalpha on cell surface, as indicated by flow cytometry (Fig. 2B).
###end p 37
###begin title 38
###xml 89 90 82 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
SIRPalpha overexpression in THP-1 cells and its effect on cell surface expression of beta2 integrins and CCR2.
###end title 38
###begin p 39
###xml 569 570 534 535 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
THP-1 cells were transfected with the empty pcDNA3.1 vector (Mock) or the SIRPalpha-encoding pcDNA3.1 vector (SIRPalpha). A: SIRPalpha protein level in SIRPalpha- or mock- transfected THP-1 cells; B: Cell surface SIRPalpha expression in Mock- and SIRPalpha-transfected THP-1 cells; C: THP-1 cell surface expression of CD11a, CD11b, CD11c and CCR2. Note that SIRPalpha overexpression significantly suppressed MCP-1-induced up-regulation of THP-1 surface expression of CD11b and CD11a but not CCR2, and that SIRPalpha overexpression did not affect the basal level of beta2 integrins. All data are mean+/-SD of three independent experiments.
###end p 39
###begin p 40
###xml 67 68 64 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 79 82 76 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Han1">[8]</xref>
###xml 84 88 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Schober1">[36]</xref>
###xml 90 94 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Simon1">[37]</xref>
###xml 749 750 731 732 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 851 852 830 831 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 883 890 862 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g002">Fig. 2C</xref>
###xml 510 515 <span type="species:ncbi:10090">mouse</span>
###xml 533 538 <span type="species:ncbi:9606">human</span>
Similar to circulating monocytes, THP-1 cells normally express beta2 integrins [8], [36], [37] and their cell surface expression levels are rapidly up-regulated by chemoattractants during inflammatory response. We next determined the alteration of cell surface expression of CD11b/CD18 and CD11a/CD18 in SIRPalpha- or mock-transfected THP-1 cells. In these experiments, SIRPalpha- or mock-transfected THP-1 cells were treated with or without 10 nM MCP-1 for 30 min and then directly labeled with PE-conjugated mouse IgG specific for human CD11a, CD11b, and CC chemokine receptor 2 (CCR2), and surface expression was analyzed using flow cytometry. The results showed that SIRPalpha overexpression in THP-1 cells did not affect the basal level of beta2 integrin expression on cell surface but significantly reduced the up-regulation of cell surface beta2 integrin expression by MCP-1 (Fig. 2C).
###end p 40
###begin title 41
SIRPalpha overexpression affects CD11b/CD18-mediated THP-1 cell functions in response to MCP-1 stimulation
###end title 41
###begin p 42
###xml 129 132 129 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Han1">[8]</xref>
###xml 146 155 146 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g003">Figure 3A</xref>
###xml 479 480 464 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 489 490 471 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 841 845 823 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Ryu1">[30]</xref>
###xml 1008 1015 986 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g003">Fig. 3B</xref>
###xml 583 588 <span type="species:ncbi:9606">human</span>
Chemokines such as MCP-1 has been reported to trigger integrin-mediated firm adhesion and subsequent transmigration of monocytes [8]. As shown in Figure 3A, MCP-1-stimulated THP-1 cells showed a significant integrin-mediated firm adhesion to TNFalpha-activated HMEC-1 monolayers. However, this firm adhesion was largely reduced in THP-1 cells with SIRPalpha overexpression. Since TNFalpha-stimulated HMEC-1 monolayers express both VCAM-1 and ICAM-1, the specific ligands for beta1 and beta2 integrins, respectively, additional adhesion assays were performed using plates coated with human recombinant ICAM-1 or VCAM-1, respectively. To estimate background adhesion, control adhesion assays were performed using THP-1 cells pretreated with Bt2cAMP, a permeable analogue of cAMP that blocks integrin-dependent firm adhesion triggered by MCP-1 [30]. SIRPalpha-transfected THP-1 cells did not show MCP-1-induced firm adhesion to plates coated with ICAM-1, while adhesion to plates coated with VCAM-1 was intact (Fig. 3B).
###end p 42
###begin title 43
SIRPalpha overexpression in THP-1 cells decreases MCP-1-stimulated adhesion.
###end title 43
###begin p 44
###xml 376 377 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
A: Micrographs and histograms show THP-1 cells adhered to HMEC-1 monolayers. Bar = 20 microm. B: MCP-1-dependent adhesion of SIRPalpha- or mock-transfected THP1 monocytes to plates coated with ICAM-1 or VCAM-1. In separate experiments, monocytes were pretreated with 50 microM Bt2cAMP to determine background integrin-independent nonspecific adhesion. All data are mean+/-SD (n = 3) of three independent experiments.
###end p 44
###begin p 45
###xml 73 74 70 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 184 187 181 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Campbell1">[7]</xref>
###xml 189 192 186 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Han1">[8]</xref>
###xml 194 198 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Sotiriou1">[38]</xref>
###xml 454 462 447 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g004">Figure 4</xref>
###xml 707 713 692 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g004">Fig. 4</xref>
Previous studies have reported that chemokine-mediated activation of beta2 integrins was essential for THP-1 cell adhesion and subsequent transmigration through endothelial monolayers [7], [8], [38]. Therefore, the effect of SIRPalpha overexpression on transendothelial migration (TEM) of THP-1 cells was examined by transmigration assay. In mock-transfected THP-1 cells, MCP-1 triggered strong THP-1 cell migration across HMEC-1 monolayers. As shown in Figure 4, more than 20% of total applied THP-1 cells were migrated across TNFalpha-activated HMEC-1 monolayers after 3 h incubation. In contrast, MCP-1-triggered transmigration of THP-1 cells that were overexpressed with SIRPalpha was strongly reduced (Fig. 4). In both mock-transfected and SIRPalpha overexpressed THP-1 cells, spontaneous migration of THP-1 cells in the absence of MCP-1 was minimal (data not shown).
###end p 45
###begin title 46
SIRPalpha overexpression reduces the MCP-1-induced migration of THP-1 cells across HMEC-1 monolayers pre-activated with 25 ng/mL TNFalpha.
###end title 46
###begin p 47
###xml 24 25 22 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
All data are mean+/-SD (n = 3) of three independent experiments.
###end p 47
###begin p 48
###xml 14 15 11 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 639 643 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Mateo1">[39]</xref>
###xml 754 762 735 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g005">Figure 5</xref>
###xml 1187 1193 1156 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g005">Fig. 5</xref>
Leukocyte beta2 integrin-mediated cell firm adhesion initiates cell shape changes and spreading of monocytes, events that must occur for subsequent cellular locomotion and transmigration. Next we investigated the effect of SIRPalpha overexpression on TNFalpha- and MCP-1-stimulated actin polymerization and cell spreading in THP-1 cells. SIRPalpha- or mock- transfected THP-1 cells were stimulated with TNFalpha or MCP-1 for 30 minutes, then fixed, and labeled with rhodamine-conjugated phalloidin to visualize actin filaments. As a control, mock-transfected THP-1 cells were pretreated with cytochalasin D to inhibit actin polymerization [39]. Labeled monocytes were mounted on coverslips and images were obtained using confocal microscopy. As shown in Figure 5, confocal microscope images showed that mock- transfected THP-1 cells exposed to TNFalpha or MCP-1 underwent morphological changes resulting in multiple pseudopods (arrowheads) with abundant actin filaments, and that this process was inhibited by cytochalasin D. In contrast, significantly less TNFalpha- or MCP-1-stimulated actin polymerization and cell spreading had occurred in THP-1 cells with SIRPalpha overexpression (Fig. 5).
###end p 48
###begin title 49
TNFalpha and MCP-1-induced cell spreading and actin polymerization in THP-1 cells.
###end title 49
###begin p 50
SIRPalpha- or mock-transfected THP-1 cells were stimulated with TNFalpha or MCP-1 for 30 minutes, fixed, and labeled with rhodamine-conjugated phalloidin to visualize actin filaments. As a negative control, mock-transfected THP-1 cells were pretreated with cytochalasin D (Mock+Cyt. D). Bar = 20 microm.
###end p 50
###begin p 51
###xml 64 65 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 76 80 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Gafa1">[40]</xref>
###xml 82 86 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Shi1">[41]</xref>
###xml 88 92 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Capo1">[42]</xref>
###xml 211 218 204 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 268 277 261 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g006">Figure 6A</xref>
###xml 413 420 406 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g006">Fig. 6A</xref>
###xml 657 666 646 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g006">Figure 6B</xref>
###xml 821 822 803 804 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 211 218 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
The phagocytic function of THP-1 cells is also dependent on beta2 integrins [40], [41], [42]. Next we examined the effect of SIRPalpha overexpression on the capacity of THP-1 cells to engulf fluorescein-labeled E. coli K12 bioparticles. As shown by confocal images in Figure 6A, the mock-transfected THP-1 cells showed a significant phagocytosis of fluorescein-conjugated bacteria particles after 3 h incubation (Fig. 6A, arrows), while in SIRPalpha-transfected THP-1 cells, uptake of fluorescein-conjugated bacteria particles was strongly reduced. The quantitative analysis of uptaking fluorescein-conjugated bacteria particles by THP-1 cells was shown in Figure 6B. Taken together, these results clearly show that SIRPalpha overexpression in THP-1 cells reduces various inflammatory responses mediated by leukocyte beta2 integrins.
###end p 51
###begin title 52
SIRPalpha overexpression in THP-1 cells impairs cell phagocytic function.
###end title 52
###begin p 53
###xml 264 265 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Fluorescently labeled bacteria were incubated with SIRPalpha- or mock-transfected THP-1 cells for 3 h. A: Images of phagocytosis of bacteria by THP-1 cells; B: Quantitative analysis of bacteria phagocytosis by THP-1 cells. Bar = 20 microm. All data are mean+/-SD (n = 4) of four independent experiments.
###end p 53
###begin title 54
Discussion
###end title 54
###begin p 55
###xml 203 204 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 364 365 346 347 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Recent studies have demonstrated that SIRPalpha is involved in regulating various inflammatory responses of leukocytes, in particular leukocyte chemotaxis and phagocytosis. By studying the leukocyte beta2 integrin-mediated functional changes in THP-1 cells after downregulation or overexpression of SIRPalpha level, we show that SIRPalpha negatively regulates beta2 integrin-mediated THP-1 cell inflammatory responses, such as adhesion, transendothelial migration and phagocytosis.
###end p 55
###begin title 56
Correlation between SIRPalpha protein level and CD11b/CD18-mediated cellular functions in THP-1 cells
###end title 56
###begin p 57
###xml 220 224 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Fujioka1">[16]</xref>
###xml 226 230 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Kharitonenkov1">[17]</xref>
###xml 297 301 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Barclay1">[14]</xref>
###xml 414 418 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Yamao1">[18]</xref>
###xml 420 424 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Okazawa1">[19]</xref>
###xml 460 464 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Smith1">[20]</xref>
###xml 469 477 457 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 493 497 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Liu2">[21]</xref>
###xml 499 503 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-deVries1">[22]</xref>
###xml 589 593 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Liu3">[23]</xref>
###xml 1108 1109 1077 1078 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1128 1129 1094 1095 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1164 1170 1130 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g001">Fig. 1</xref>
###xml 1355 1359 1313 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Kong1">[43]</xref>
###xml 1473 1474 1424 1425 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1493 1494 1441 1442 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1618 1624 1562 1568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g002">Fig. 2</xref>
###xml 1625 1625 1569 1569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g003"/>
###xml 1625 1625 1569 1569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g004"/>
###xml 1625 1625 1569 1569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g005"/>
###xml 1625 1626 1569 1570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003291-g006">6</xref>
###xml 1831 1832 1764 1765 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1961 1962 1887 1888 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2011 2012 1934 1935 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2208 2209 2124 2125 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2285 2286 2198 2199 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2456 2457 2358 2359 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1273 1278 <span type="species:ncbi:10090">mouse</span>
Ligation of SIRPalpha with its extracellular ligand CD47 results in phosphorylations of SIRPalpha ITIMs, which in turn, leads to their association with SH2-domain-containing protein tyrosine phosphotases SHP-1 and SHP-2 [16], [17] to delivers signals that regulate a variety of cellular functions [14]. Binding of SIRPalpha by antibody or CD47 recombinant inhibits many leukocyte functions, including phagocytosis [18], [19], tumour-necrosis factor production [20] and in vitro transmigration [21], [22]. Activation of SIRPalpha by arterial elastic laminae also inhibits monocyte adhesion [23]. Fibroblasts expressing a SIRPalpha mutant lacking ITIMs-containing cytoplasmic tail showed increased formation of focal adhesions and actin stress fibres in response to interaction with extracellular matrix, suggesting that SIRPalpha is also involved in mediating outside-in signal transduction during cell-matrix interaction. Using THP-1 cell as model cell line, here we show that SIRPalpha protein level is downregulated by AGEs treatment, which is also correlated to an enhanced cell surface expression of beta2 integrins and beta2 integrins-mediated cell adhesion (Fig. 1). The finding of SIRPalpha reduction in AGEs-treated THP-1 cells is supported by a recent report that mouse macrophages have lower SIRPalpha expression level following LPS stimulation [43]. The correlation between SIRPalpha expression level and chemoattractant-induced cell surface upregulation of beta2 integrins and beta2 integrins-mediated THP-1 cell inflammatory responses is further characterized in THP-1 cells overexpressed with SIRPalpha (Fig. 2-6). The results not only confirm the inhibitory function of SIRPalpha on THP-1 inflammatory responses, but also indicated that the role of SIRPalpha in THP-1 cells is through affecting the functions of beta2 integrins, particularly CD11b/CD18. It is worthy to note that overexpression of SIRPalpha does not alter the basal level of beta2 integrin expression but the upregulation of beta2 integrins by MCP-1 stimulation, suggesting that SIRPalpha is one of essential molecules along the signal pathways that may regulate the synthesis, transportation and translocation process of beta2 integrins. Moreover, if AGEs and other inflammatory factors can affect beta2 integrin expression and function through down-regulating SIRPalpha, it might be reasonable to conclude that SIRPalpha can mediate an inside-out signal in regulating beta2 integrin function.
###end p 57
###begin title 58
SIRPalpha as a negative regulator in monocyte recruitment during inflammation
###end title 58
###begin p 59
###xml 22 23 19 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 135 139 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Zhang1">[32]</xref>
###xml 141 145 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Shahabuddin1">[44]</xref>
###xml 147 151 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Papayannopoulou1">[45]</xref>
###xml 153 157 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Weber1">[46]</xref>
###xml 337 340 334 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Han1">[8]</xref>
###xml 342 346 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Aiello1">[47]</xref>
###xml 348 352 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-vanRoyen1">[48]</xref>
###xml 466 474 463 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 474 477 471 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Han1">[8]</xref>
###xml 602 606 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-vanRoyen1">[48]</xref>
###xml 807 808 797 798 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 887 888 874 875 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1547 1548 1519 1520 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1554 1555 1523 1524 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1564 1565 1530 1531 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1626 1630 1592 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Brown1">[49]</xref>
###xml 1856 1857 1819 1820 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2087 2091 2042 2046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003291-Yamao1">[18]</xref>
###xml 2285 2286 2233 2234 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2422 2423 2363 2364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The expression of beta2 integrins and adhesion molecules in monocytes is regulated by chemokines such as MCP-1, SDF-1 alpha and RANTES [32], [44], [45], [46]. The positive correlation between CD11b expression in circulating monocytes and the degree of monocyte infiltration into the proatherogenic vascular wall has been well-documented [8], [47], [48]. The increased expression of monocyte CD11b under pro-inflammatory conditions enhanced MCP-1-mediated chemotaxis in vitro[8], induced excess monocyte adhesion to vascular endothelium, and increased formation of neointima and atherosclerotic plaques [48]. Although SIRPalpha overexpression did not affect surface expression of CCR2, the receptor for MCP-1, it resulted in a profound reduction of MCP-1-mediated upregulation of THP-1 cell cell surface beta2 integrins and THP-1 cell TEM. In addition to reduction of CD11b and other beta2 integrins, our study has also demonstrated that overexpressing SIRPalpha in THP-1 cells display less cell spreading and actin polymerization in response to chemokine stimulation. The mechanism by which SIRPalpha modulates chemokine-induced cell spreading and actin polymerization is unknown although several possibilities exist: a) directly activates protein phosphatase and initiates signal pathways that attenuate filament actin polymerization and cell spreading, and b) binding to integrin-associated protein CD47 and modulating the integrin functions. Since SIRPalpha is a cellular ligand of CD47, which can augment the functions of integrins of the beta1, beta2 and beta3 families via initiating heterotrimeric Gi protein signaling [49], thus modulating a range of cell activities including cell motility and adhesion, and leukocyte adhesion, migration and phagocytosis. Indeed, phagocytosis of bacteria by THP-1 cells, an event that is largely dependent on beta2 integrin and actin polymerization, was significantly reduced by overexpression of SIRPalpha. This result was in agreement with the previous finding that SIRPalpha contributes to down-regulating the macrophage phagocytic response [18]. In summary, the present study demonstrates for the first time that SIRPalpha overexpression potently inhibits the various inflammatory responses of THP-1 monocytes/macrophages mediated by beta2 integrins. The induction of SIRPalpha expression in THP-1 cells led to a reduction of chemokine-induced cell surface expression of beta2 integrins, which eventually resulted in less cell adhesion, cellular spreading, cell transmigration and phagocytosis. This observation suggests that SIRPalpha may function to decrease transendothelial migration of monocytes or other circulating leukocytes, reduce the burden of inflammatory cells in atheroma, and ultimately decrease plaque mass under atherogenic conditions. Since migration of monocytes across blood vessel lining endothelial monolayers is a key component during early stage of atherosclerosis, such an outcome would indicate that SIRPalpha overexpression in monocytes or macrophages has an anti-atherogenic effect and that SIRPalpha is a potential target in therapeutical implications.
###end p 59
###begin p 60
The authors thank Dr. E.W. Ades (Centers for Disease Control and Prevention, Atlanta, GA) and Dr. Yuan Liu (Department of Biology, Georgia State University, Atlanta, GA) for kindly gift of the immortalized HMEC-1 and SIRPalpha expression vectors, respectively. The authors also thank Mr. Bihn Ha and Ms Celia Chen for excellent technical assistance.
###end p 60
###begin title 61
References
###end title 61
###begin article-title 62
The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions.
###end article-title 62
###begin article-title 63
The pathogenesis of atherosclerosis: a perspective for the 1990s.
###end article-title 63
###begin article-title 64
Leukocyte recruitment into developing atherosclerotic lesions: the complex interaction between multiple molecules keeps getting more complex.
###end article-title 64
###begin article-title 65
###xml 144 148 <span type="species:ncbi:10090">mice</span>
A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice.
###end article-title 65
###begin article-title 66
The combined role of P- and E-selectins in atherosclerosis.
###end article-title 66
###begin article-title 67
Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.
###end article-title 67
###begin article-title 68
Chemokines and the arrest of lymphocytes rolling under flow conditions.
###end article-title 68
###begin article-title 69
LDL activates signaling pathways leading to an increase in cytosolic free calcium and stimulation of CD11b expression in monocytes.
###end article-title 69
###begin article-title 70
SHPS-1, a multifunctional transmembrane glycoprotein.
###end article-title 70
###begin article-title 71
Integrin-associated protein is a ligand for the P84 neural adhesion molecule.
###end article-title 71
###begin article-title 72
Identification of major binding proteins and substrates for the SH2-containing protein tyrosine phosphatase SHP-1 in macrophages.
###end article-title 72
###begin article-title 73
MFR, a putative receptor mediating the fusion of macrophages.
###end article-title 73
###begin article-title 74
MyD-1 (SIRPalpha) regulates T cell function in the absence of exogenous danger signals, via a TNFalpha-dependent pathway.
###end article-title 74
###begin article-title 75
The SIRP family of receptors and immune regulation.
###end article-title 75
###begin article-title 76
SIRPbeta1 is expressed as a disulfide-linked homodimer in leukocytes and positively regulates neutrophil transepithelial migration.
###end article-title 76
###begin article-title 77
A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion.
###end article-title 77
###begin article-title 78
A family of proteins that inhibit signalling through tyrosine kinase receptors.
###end article-title 78
###begin article-title 79
Negative regulation of platelet clearance and of the macrophage phagocytic response by the transmembrane glycoprotein SHPS-1.
###end article-title 79
###begin article-title 80
Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system.
###end article-title 80
###begin article-title 81
A novel MyD-1 (SIRP-1alpha) signaling pathway that inhibits LPS-induced TNFalpha production by monocytes.
###end article-title 81
###begin article-title 82
Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration.
###end article-title 82
###begin article-title 83
Signal-regulatory protein alpha-CD47 interactions are required for the transmigration of monocytes across cerebral endothelium.
###end article-title 83
###begin article-title 84
Negative regulation of monocyte adhesion to arterial elastic laminae by signal regulatory protein alpha and Src homology 2 domain-containing protein-tyrosine phosphatase-1.
###end article-title 84
###begin article-title 85
SHPS-1 regulates integrin-mediated cytoskeletal reorganization and cell motility.
###end article-title 85
###begin article-title 86
Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
###end article-title 86
###begin article-title 87
Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation.
###end article-title 87
###begin article-title 88
CD11b/CD18-dependent interactions of neutrophils with intestinal epithelium are mediated by fucosylated proteoglycans.
###end article-title 88
###begin article-title 89
###xml 41 46 <span type="species:ncbi:9606">human</span>
HMEC-1: establishment of an immortalized human microvascular endothelial cell line.
###end article-title 89
###begin article-title 90
Critical Role of Mac-1 Sialyl Lewis X Moieties in Regulating Neutrophil Degranulation and Transmigration.
###end article-title 90
###begin article-title 91
Overexpression of uncoupling protein 2 in THP1 monocytes inhibits beta2 integrin-mediated firm adhesion and transendothelial migration.
###end article-title 91
###begin article-title 92
L- and P-selectins, but not CD49d (VLA-4) integrins, mediate monocyte initial attachment to TNF-alpha-activated vascular endothelium under flow in vitro.
###end article-title 92
###begin article-title 93
Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.
###end article-title 93
###begin article-title 94
The protease-activated receptor-2 upregulates keratinocyte phagocytosis.
###end article-title 94
###begin article-title 95
###xml 155 160 <span type="species:ncbi:9606">human</span>
Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
###end article-title 95
###begin article-title 96
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice.
###end article-title 96
###begin article-title 97
Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions.
###end article-title 97
###begin article-title 98
Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18).
###end article-title 98
###begin article-title 99
Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin.
###end article-title 99
###begin article-title 100
Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization.
###end article-title 100
###begin article-title 101
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus downregulates complement receptors (CR3, CR4) and decreases phagocytosis by macrophages.
###end article-title 101
###begin article-title 102
Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1.
###end article-title 102
###begin article-title 103
###xml 0 17 <span type="species:ncbi:777">Coxiella burnetii</span>
Coxiella burnetii avoids macrophage phagocytosis by interfering with spatial distribution of complement receptor 3.
###end article-title 103
###begin article-title 104
LPS-induced down-regulation of signal regulatory protein {alpha} contributes to innate immune activation in macrophages.
###end article-title 104
###begin article-title 105
Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines.
###end article-title 105
###begin article-title 106
The role of G-protein signaling in hematopoietic stem/progenitor cell mobilization.
###end article-title 106
###begin article-title 107
Specific activation of leukocyte beta2 integrins lymphocyte function-associated antigen-1 and Mac-1 by chemokines mediated by distinct pathways via the alpha subunit cytoplasmic domains.
###end article-title 107
###begin article-title 108
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice.
###end article-title 108
###begin article-title 109
###xml 117 121 <span type="species:ncbi:10090">mice</span>
Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression.
###end article-title 109
###begin article-title 110
Integrin-associated protein (CD47): an unusual activator of G protein signaling.
###end article-title 110
###begin p 111
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 111
###begin p 112
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported in part by China Basic Science 973 program (CYZ, KZ).
###end p 112

